Other Issues:
previous
|
next
|
latest
|
archive
Volume 2(3); September 2006
Editorial Foreword
Metabolic Syndrome: Sign of Things to Come
Reza Tabrizchi
Vasc Health Risk Manag.
2006 September;
2
(3)
: 193–194.
Published online 2006 September.
PMCID:
PMC1993988
|
Full Text
|
PDF–41K
|
Reviews
A Review of Telmisartan in the Treatment of Hypertension: Blood Pressure Control in the Early Morning Hours
Philippe Gosse
Vasc Health Risk Manag.
2006 September;
2
(3)
: 195–201.
Published online 2006 September.
PMCID:
PMC1993985
|
Abstract
|
Full Text
|
PDF–91K
|
Pramlintide in the Management of Insulin-Using Patients with Type 2 and Type 1 Diabetes
John Pullman, Tamara Darsow, and Juan P Frias
Vasc Health Risk Manag.
2006 September;
2
(3)
: 203–212.
Published online 2006 September.
PMCID:
PMC1993989
|
Abstract
|
Full Text
|
PDF–133K
|
Angiogenesis in Cancer
Naoyo Nishida, Hirohisa Yano, Takashi Nishida, Toshiharu Kamura, and Masamichi Kojiro
Vasc Health Risk Manag.
2006 September;
2
(3)
: 213–219.
Published online 2006 September.
PMCID:
PMC1993983
|
Abstract
|
Full Text
|
PDF–108K
|
Critical Appraisal of C-Reactive Protein Throughout the Spectrum of Cardiovascular Disease
Raed Osman, Philippe L L'Allier, Nader Elgharib, and Jean-Claude Tardif
Vasc Health Risk Manag.
2006 September;
2
(3)
: 221–237.
Published online 2006 September.
PMCID:
PMC1993979
|
Abstract
|
Full Text
|
PDF–226K
|
Effect of Alcohol on Risk of Coronary Heart Disease and Stroke: Causality, Bias, or a Bit of Both?
Jonathan R Emberson and Derrick A Bennett
Vasc Health Risk Manag.
2006 September;
2
(3)
: 239–249.
Published online 2006 September.
PMCID:
PMC1993990
|
Abstract
|
Full Text
|
PDF–107K
|
A Review of Omega-3 Ethyl Esters for Cardiovascular Prevention and Treatment of Increased Blood Triglyceride Levels
Clemens von Schacky
Vasc Health Risk Manag.
2006 September;
2
(3)
: 251–262.
Published online 2006 September.
PMCID:
PMC1993981
|
Abstract
|
Full Text
|
PDF–99K
|
Beneficial Effect of Low Ethanol Intake on the Cardiovascular System: Possible Biochemical Mechanisms
Sudesh Vasdev, Vicki Gill, and Pawan K Singal
Vasc Health Risk Manag.
2006 September;
2
(3)
: 263–276.
Published online 2006 September.
PMCID:
PMC1993980
|
Abstract
|
Full Text
|
PDF–721K
|
Insulin Detemir in the Treatment of Type 1 and Type 2 Diabetes
Jean-Christophe Philips and André Scheen
Vasc Health Risk Manag.
2006 September;
2
(3)
: 277–283.
Published online 2006 September.
PMCID:
PMC1993987
|
Abstract
|
Full Text
|
PDF–81K
|
Metabolic Syndrome: The Danger Signal in Atherosclerosis
Patrick Mathieu, Philippe Pibarot, and Jean-Pierre Després
Vasc Health Risk Manag.
2006 September;
2
(3)
: 285–302.
Published online 2006 September.
PMCID:
PMC1993986
|
Abstract
|
Full Text
|
PDF–829K
|
Nebivolol: A Novel Beta-Blocker with Nitric Oxide-Induced Vasodilatation
Robert Weiss
Vasc Health Risk Manag.
2006 September;
2
(3)
: 303–308.
Published online 2006 September.
PMCID:
PMC1993984
|
Abstract
|
Full Text
|
PDF–67K
|
Methodological Issues in Cardiovascular Epidemiology: The Risk of Determining Absolute Risk Through Statistical Models
Demosthenes B Panagiotakos and Vassilis Stavrinos
Vasc Health Risk Manag.
2006 September;
2
(3)
: 309–315.
Published online 2006 September.
PMCID:
PMC1993982
|
Abstract
|
Full Text
|
PDF–87K
|
Original Research
A Large Scale Study of Angiotensin II Inhibition Therapy in an Elderly Population: the Chance Study
Roland Asmar and Sophie Nisse-Durgeat
Vasc Health Risk Manag.
2006 September;
2
(3)
: 317–323.
Published online 2006 September.
PMCID:
PMC1993978
|
Abstract
|
Full Text
|
PDF–93K
|
Correction
|
Other Issues:
previous
|
next
|
latest
|
archive
